National Epilepsy Plan and Advisory Council

Full Title:
National Plan for Epilepsy Act

Summary#

This bill would create a coordinated federal program called the National Plan for Epilepsy. It requires the Department of Health and Human Services (HHS) Secretary to develop, update, and report on a national plan to prevent, diagnose, treat, and cure epilepsy. The plan aims to coordinate research, improve care, boost public awareness, and measure progress.

  • Main change: Establishes the National Plan for Epilepsy inside the Public Health Service Act and directs the HHS Secretary to run it.
  • Requires annual assessments of the Nation’s progress and an annual report to Congress on federally funded epilepsy efforts.
  • Creates an Advisory Council on Epilepsy Research, Care, and Services made up of Federal agency representatives and expert non‑Federal members (patients, caregivers, clinicians, researchers, and nonprofits).
  • Requires regular public meetings, periodic joint meetings with other organizations, and public reports from the Advisory Council.
  • Requires agencies inside and outside HHS that have epilepsy data to share that data with the Secretary as needed for reports.
  • Sunset: The section ends on December 31, 2035 (the program would stop then unless renewed).

What it means for you#

  • People with epilepsy and caregivers: There would be a coordinated federal effort to improve diagnosis, care coordination, access to specialists, public awareness, and efforts to reduce epilepsy‑related deaths. The bill asks for recommendations to reduce financial burdens and disparities.
  • Patients seeking care: The Advisory Council and the plan aim to improve early diagnosis and access to specialized care, which could influence clinical guidance and referral systems over time.
  • Researchers and academic institutions: The plan would coordinate federal research efforts and call for stronger data systems and surveillance. This could lead to more coordinated research priorities and possibly new research opportunities.
  • Health care providers and health systems: The bill asks for steps to improve coordination of care and clinical services; this could lead to new guidance, pilot programs, or funding opportunities, but the bill itself does not mandate changes in clinical practice.
  • Federal agencies (NIH, CDC, FDA, CMS, HRSA, DOD, VA, etc.): These agencies must participate in the Advisory Council and share relevant data with HHS to support the reports and assessments. This could increase interagency coordination and reporting duties.
  • Nonprofit epilepsy organizations: The bill requires representation from such organizations on the Advisory Council and requests that public comments be considered, giving them a formal advisory role.
  • General public and taxpayers: The bill calls for annual reporting to Congress on federal epilepsy activities. The bill does not itself create new benefits for most people, but it could change how federal resources and attention are directed to epilepsy.

Expenses#

No publicly available information.

  • The bill does not authorize specific new funding or appropriate money.
  • This could mean HHS and other agencies may need to use existing budgets or seek new appropriations to run the plan, hold meetings, prepare reports, and build or expand data systems.
  • Agencies required to share data and participate in the Advisory Council may face increased administrative and staff time costs.
  • If Congress chooses to fund the plan later, there could be direct federal spending for coordination, data infrastructure, research, and program activities.

Proponents' View#

  • The bill appears intended to make federal efforts on epilepsy more coordinated and focused.
  • It aims to identify research priorities and reduce duplication across agencies by creating a single national plan.
  • The plan could improve early diagnosis, access to specialists, and care coordination for people with epilepsy.
  • Better data sharing and regular assessments could help measure progress and guide future investments.
  • Including patients, caregivers, clinicians, researchers, and nonprofits on the Advisory Council is meant to ensure diverse perspectives inform federal actions.

Opponents' View#

  • One concern is that the bill does not include specific funding. It is unclear how HHS and other agencies will pay for the increased coordination, reporting, and data work.
  • The bill leaves many details to the Secretary, so it is unclear what exact activities will be prioritized or how success will be measured.
  • Requiring agencies to share data raises questions about privacy protections and legal limits on data sharing; the bill does not explain how those issues will be handled.
  • The reporting and meeting schedule could create added administrative work for federal agencies without clear resources to cover it.
  • The sunset date (December 31, 2035) may limit long‑term planning unless Congress extends the program.